BXA0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lavipharm SA

Watchlist Manager

Watchlist

Price: 1.486 EUR 0.13% Market Closed

Market Cap: €278.8m

L	Lavipharm SA F:BXA0	GR
F	Forte Minerals Corp F:2OA	CA
	Catenon SA MAD:COM	ES
R	Revenga Ingenieros SA MAD:RSS	ES
E	Eisen und Huettenwerke AG SWB:EIS	DE
W	Wolford AG DUS:WOF	AT
B	BlueScope Steel Ltd OTC:BLSFF	AU
M	MPC Container Ships ASA F:MP2	NO
	Eurocommercial Properties NV AEX:ECMPA	NL
	Gale Pacific Ltd ASX:GAP	AU
N	Nexans SA XMUN:NXS	FR
A	Asia Enterprises Holding Ltd SGX:A55	SG
	F I P P SA PAR:FIPP	FR
S	Siemens AG SWB:SIE	DE
P	Petroleo Brasileiro SA Petrobras BMV:PBRN	BR
	Power Assets Holdings Ltd F:HEH0	HK

Profitability Summary

Lavipharm SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

47%

Gross Margin is Increasing

40% > 47%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

12%

Operating Margin is Increasing

9% > 14%

Low Net Margin

Low 3Y Average Net Margin

10%

Net Margin is Increasing

2% > 8%

Negative Free Cash Flow Margin

-12%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-62% > -12%

Positive ROE

10%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.